Back to search results

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

IC-MPGN

Locations
  • Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular, Orange, California, United States
  • UCSF, San Francisco, California, United States
  • Olive View UCLA Medical Center, Sylmar, California, United States
  • Childrens Hospital Colorado, Aurora, Colorado, United States
  • Nicklaus Childrens Hospital, Miami, Florida, United States
  • Massachusetts General Hospital, Boston, Massachusetts, United States
  • Boston Univ School of Medicine, Boston, Massachusetts, United States
  • University of Minnesota, Minneapolis, Minnesota, United States
  • Washington University in St Louis, St Louis, Missouri, United States
  • University of New Mexico, Albuquerque, New Mexico, United States
  • Col Uni Med Center New York Presby, New York, New York, United States
  • University Of Cincinnati, Cincinnati, Ohio, United States
  • OHSU Dept of Nephrology, Portland, Oregon, United States
  • Univ of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
  • UT Southwestern Medical Center, Dallas, Texas, United States
  • Prolato Clinical Research Center, Houston, Texas, United States
  • Baylor Scott and White Research, Temple, Texas, United States
  • University of Utah, Salt Lake City, Utah, United States
  • University of Wisconsin, Madison, Wisconsin, United States
  • Novartis Investigative Site, CABA, Buenos Aires, Argentina
  • Novartis Investigative Site, CABA, Buenos Aires, Argentina
  • Novartis Investigative Site, Buenos Aires, Argentina
  • Novartis Investigative Site, CABA, Argentina
  • Novartis Investigative Site, Santa Fe, Argentina
  • Novartis Investigative Site, Fortaleza, Ceará, Brazil
  • Novartis Investigative Site, Brasília, Federal District, Brazil
  • Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site, Recife, Pernambuco, Brazil
  • Novartis Investigative Site, Niterói, Rio de Janeiro, Brazil
  • Novartis Investigative Site, Rio de Janeiro, Rio de Janeiro, Brazil
  • Novartis Investigative Site, Natal, Rio Grande do Norte, Brazil
  • Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil
  • Novartis Investigative Site, Botucatu, São Paulo, Brazil
  • Novartis Investigative Site, Santo André, São Paulo, Brazil
  • Novartis Investigative Site, Sao Jose Rio Preto, São Paulo, Brazil
  • Novartis Investigative Site, São Paulo, São Paulo, Brazil
  • Novartis Investigative Site, São Paulo, São Paulo, Brazil
  • Novartis Investigative Site, São Paulo, São Paulo, Brazil
  • Novartis Investigative Site, Salvador, Brazil
  • Novartis Investigative Site, Etobicoke, Ontario, Canada
  • Novartis Investigative Site, Toronto, Ontario, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Prague, Czechia
  • Novartis Investigative Site, Aarhus N, Denmark
  • Novartis Investigative Site, Copenhagen, Denmark
  • Novartis Investigative Site, Marseille, France
  • Novartis Investigative Site, Montpellier, France
  • Novartis Investigative Site, Paris, France
  • Novartis Investigative Site, Rennes, France
  • Novartis Investigative Site, Toulouse, France
  • Novartis Investigative Site, Munich, Bavaria, Germany
  • Novartis Investigative Site, Würzburg, Bavaria, Germany
  • Novartis Investigative Site, Dresden, Saxony, Germany
  • Novartis Investigative Site, Jena, Thuringia, Germany
  • Novartis Investigative Site, Berlin, Germany
  • Novartis Investigative Site, Essen, Germany
  • Novartis Investigative Site, Hamburg, Germany
  • Novartis Investigative Site, Hanover, Germany
  • Novartis Investigative Site, Mainz, Germany
  • Novartis Investigative Site, Ulm, Germany
  • Novartis Investigative Site, Athens, Greece
  • Novartis Investigative Site, Chaïdári, Greece
  • Novartis Investigative Site, Heraklion Crete., Greece
  • Novartis Investigative Site, Ioannina, Greece
  • Novartis Investigative Site, Pátrai, Greece
  • Novartis Investigative Site, Thessaloniki, Greece
  • Novartis Investigative Site, Bangalore, Karnataka, India
  • Novartis Investigative Site, Nagpur, Maharashtra, India
  • Novartis Investigative Site, Pune, Maharashtra, India
  • Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India
  • Novartis Investigative Site, Hyderabad, Telangana, India
  • Novartis Investigative Site, Haifa, Israel
  • Novartis Investigative Site, Jerusalem, Israel
  • Novartis Investigative Site, Petah Tikva, Israel
  • Novartis Investigative Site, Bari, BA, Italy
  • Novartis Investigative Site, Ranica, BG, Italy
  • Novartis Investigative Site, Brescia, BS, Italy
  • Novartis Investigative Site, Milan, MI, Italy
  • Novartis Investigative Site, Roma, RM, Italy
  • Novartis Investigative Site, Torino, TO, Italy
  • Novartis Investigative Site, Naples, Italy
  • Novartis Investigative Site, Fuchū, Tokyo, Japan
  • Novartis Investigative Site, Hachiōji, Tokyo, Japan
  • Novartis Investigative Site, Okayama, Japan
  • Novartis Investigative Site, Osaka, Japan
  • Novartis Investigative Site, Groningen, Netherlands
  • Novartis Investigative Site, Poznan, Greater Poland Voivodeship, Poland
  • Novartis Investigative Site, Bialystok, Poland
  • Novartis Investigative Site, Krakow, Poland
  • Novartis Investigative Site, Olsztyn, Poland
  • Novartis Investigative Site, Warsaw, Poland
  • Novartis Investigative Site, Warsaw, Poland
  • Novartis Investigative Site, Wroclaw, Poland
  • Novartis Investigative Site, Martin, Slovakia, Slovakia
  • Novartis Investigative Site, Košice, Slovakia
  • Novartis Investigative Site, Seoul, Korea, South Korea
  • Novartis Investigative Site, Seoul, South Korea
  • Novartis Investigative Site, Pamplona, Navarre, Spain
  • Novartis Investigative Site, Almería, Spain
  • Novartis Investigative Site, Barcelona, Spain
  • Novartis Investigative Site, Barcelona, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Salamanca, Spain
  • Novartis Investigative Site, Bern, Switzerland
  • Novartis Investigative Site, Lausanne, Switzerland
  • Novartis Investigative Site, Zurich, Switzerland
  • Novartis Investigative Site, Kaohsiung City, Taiwan
  • Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)
  • Novartis Investigative Site, Izmir, Karsiyaka, Turkey (Türkiye)
  • Novartis Investigative Site, Köseköy, Kocaeli, Turkey (Türkiye)
  • Novartis Investigative Site, Kayseri, Melikgazi, Turkey (Türkiye)
  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
  • Novartis Investigative Site, Mersin, Yenisehir, Turkey (Türkiye)
  • Novartis Investigative Site, Belfast, United Kingdom
  • Novartis Investigative Site, Cardiff, United Kingdom
  • Novartis Investigative Site, London, United Kingdom
  • Novartis Investigative Site, London, United Kingdom
  • Novartis Investigative Site, Manchester, United Kingdom
  • Novartis Investigative Site, Salford, United Kingdom
  • Novartis Investigative Site, Ho Chi Minh City, Vietnam
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)